Press releases
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
- Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference
- Insmed To Present at Three March Conferences
- Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health
- Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
- Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 148.56m |
Free float | 146.94m |
P/E (TTM) | -- |
Market cap | 3.80bn USD |
EPS (TTM) | -5.35 USD |
Data delayed at least 15 minutes.
More ▼